Table 4.
Changes in Anatomical and Volumetric Functional Metrics Early (1 month) after IAT for the 2 Readers for Targeted Lesions (N = 42)
Reader 1 |
Reader 2 |
|||||||
---|---|---|---|---|---|---|---|---|
Parameter | Before Treatment | After Treatment | Mean percentage change (%) | P value* | Before Treatment | After Treatment | Mean percentage change (%) | P value* |
Anatomical metrics | ||||||||
RECIST (cm) | 4.3±3.4 | 4.5±3.6 | 4.2±6.3 | 0.4 | 4.2±3.4 | 4.4±3.6 | 4.3±7.7 | 0.3 |
mRECIST(cm)⁎⁎ | 3.3±3.3 | 2.8±3.4 | − 16.9±2.2 | 0.01 | 3.1±3.2 | 2.4±3.3 | − 22.8±3.8 | 0.005 |
EASL (cm2)⁎⁎ | 14.8±33.3 | 12.3±32.5 | − 16.8±2.5 | 0.02 | 13.5±32.7 | 10.8±32.2 | − 20.6±1.7 | 0.02 |
Volumetric metrics | ||||||||
Hepatic Arterial (%) | 31.4±25.1 | 23.9±24.5 | − 23.9±2.3 | 0.14 | 31.5±25.2 | 23.9±24.5 | − 24.2±2.9 | 0.14 |
Portal Venous (%) | 63.8±33.8 | 43.1±28.7 | − 32.4±15.3 | 0.0001 | 63.6±34.2 | 42.6±28.3 | − 33.0±17.0 | < 0.0001 |
ADC (× 10− 3 mm2/s)⁎⁎⁎ | 1.408±.0353 | 1.592±0.383 | 13.1±8.5 | 0.0007 | 1.413±0.358 | 1.571±0.392 | 11.2±9.3 | 0.003 |
Note. Unless otherwise indicated, data are means ± standard deviations. *P value is obtained from independent-samples t test.
mRECIST and EASL could not be measured in 7 (17%) lesions by Reader 1 and 9 (21%) lesions by Reader 2.
ADC map was not available in 5 targeted lesions.